---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-199180"
form_type: "8-K"
ticker: "TARS"
cik: "0001819790"
company_name: "Tarsus Pharmaceuticals, Inc."
filed_at: "2023-07-31T23:59:59+00:00"
generated_at: "2026-06-12T22:14:33.957076+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# Tarsus Pharmaceuticals launches proposed underwritten public offering of common stock

## Summary
- Company commenced proposed underwritten public offering of common stock under existing shelf registration.
- Terminated unused ATM prospectus; no shares were ever sold under that program.
- Sales Agreement with Jefferies LLC remains in effect, pending new prospectus.
- No details on size, pricing, or timing of the offering were disclosed.

## SEC filing metadata
- accession: 0001193125-23-199180
- form_type: 8-K
- ticker: TARS
- cik: 0001819790
- company_name: Tarsus Pharmaceuticals, Inc.
- filed_at: 2023-07-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819790/000119312523199180/0001193125-23-199180-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819790/000119312523199180/d473618d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-199180
- JSON: https://secwatch.observer/filing/0001193125-23-199180.json
- Plain text: https://secwatch.observer/filing/0001193125-23-199180.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.